Immunai is a biotech company mapping the immune system at unprecedented scale & granularity to develop the next-generation of immunomodulatory therapeutics. Our therapeutics engine is built on an integrated immune data platform (AMICA) that combines multi-omic single cell analysis with machine learning and functional genomics to integrate translational disease biology with causal immune insights.
Privately Funded Company
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):